English

    Overview

  • Dr. Sandeep Satsangi is a top hepatologist and liver transplant doctor in Kanakapura Road, Bangalore, with over 20+ years of experience in treating complex liver diseases. He is currently practising as a Lead Consultant – Hepatology and Transplant Hepatology  at Manipal Hospital, Kanakapura Road. Dr. Sandeep is particularly known for his evidence-based practice and patient-centric care for advanced liver conditions, liver transplantation, and managing multiorgan complications.

  • Dr. Satsangi completed his MBBS from MNR Medical College, Sangareddy, and went on to earn an MD in Internal Medicine from Kasturba Medical College, Mangalore, under Manipal University, which he completed as the university topper. With a particular interest in hepatological disorders, he completed his DM in Hepatology and Liver Transplantation at the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh. With extensive training and residency at his alma mater, Dr. Satsangi gained hands-on experience in managing fatty liver, portal hypertension, acute and chronic liver disease, cirrhosis, viral hepatitis, liver cancer, and acute liver failure.

  • At Manipal Hospital Kanakapura Road, Dr. Sandeep Satsangi plays a pivotal role in the liver transplant programme. He is deeply involved in both pre- and post-transplant patient and donor care, ensuring the smooth surgical and regenerative journey of live donors. A dedicated academic, his research contributions include award-winning papers presented at major international conferences (APASL, AASLD), covering topics such as transplantation outcomes, Hepatitis C management, and ACLF strategies.

  • Dr. Sandeep Satsangi has actively participated in telemedicine initiatives like the ‘ECHO’ programme in Punjab, effectively training community doctors in early liver disease detection and care. He also served as an Assistant Editor for the Journal of Clinical and Experimental Hepatology, underscoring his expertise in scientific review and publication. Known for his compassionate, multilingual ability to converse in English, Hindi, Telugu, Punjabi, and Kannada), Dr. Satsangi seamlessly integrates cutting-edge medical science with personalised care, making him a preferred liver specialist in Kanakapura Road, Bangalore.

    • Field of Expertise

  • Complex Hepatobiliary Conditions.
  • Non-alcoholic fatty liver disease.
  • Alcoholic liver diseases.
  • Cirrhosis of the liver.
  • Acute liver failure.
  • Liver Cancer.
  • Liver Transplantation.
  • Liver Cancer.
  • Liver Transplantation.

    • Languages Spoken

  • English
  • Hindi
  • Telugu
  • Kannada

    • Awards & Achievements

  • MD: Best outgoing student 2011 batch, scored first rank in the Cardiology-Respiratory Medicine exam, and secured first prize in the M.D intercollegiate quiz competition (2013) held at Cochin, India.
  • DM: Topped the exam held at the distinguished institute of PGI, Chandigarh in 2016.
  • He also received the FIRST prize in the plenary session for the best paper award for an oral presentation on “Monocyte HLA-DR expression, neutrophil oxidative burst capacity and cytokine analysis in patients with decompensated cirrhosis with and without acute-on-chronic liver failure (ACLF)” in Delhi.
  • Served as the Assistant Editor of the prestigious Journal of Clinical and Experimental Hepatology from July 2016 to July 2017, which is an International peer-reviewed journal of Hepatology.
  • Actively assisted Prof. R.K Dhiman and his team in the process of devising the scientific program and abstract evaluation for INASL 2016 & ISHEN 2017.
  • Was actively involved in training the community level physicians in the state of Punjab, India in the field of Hepatology under the guidance of Prof. R.K Dhiman via. the program ‘ECHO’, which involves telemedicine services.

    • Talks & Publications

  • Hepatic Visceral Crisis in Breast Cancer: Targeting an Old Enemy With “Precision” Resulting in Excellent Outcomes. JCEH 2025.
  • Exploring the prevalence, clinical parameters and impact of culture proven ascitic fluid infections in Cirrhosis: A multi-center study. JCEH 2025.
  • The potential liver donor with tuberculosis: A fresh look at international recommendations based on a survey of practice in Indian liver transplant centres. National Med Journal 2022.
  • Fatal Herpes Simplex Hepatitis in a Live Liver Donor. JCEH 2025.
  • Kaur S, Satsangi S et al. Awareness regarding hepatitis B prevention and management of hepatitis B virus positive patients among nurses. J Postgrad Med Edu Res 2023.
  • Satsangi S, Taneja S. Abnormal LFTs in Rheumatic diseases. Rheumatology Clinics 2023.
  • Satsangi S, Taneja S. Anti Tubercular Therapy related hepatitis. Tuberculosis and GIT 2022.
  • Satsangi S et al. Current and new drugs for COVID 19 treatment and its effects on the liver. J Clin Transl Hepatol 2021.
  • Decentralized Care with Generic Direct-Acting Antivirals in the Management of Chronic Hepatitis C in a Public Health Care Setting. J Hepatol. July 2019.
  • Direct-acting antiviral Therapy Is Safe and Effective in Pediatric Chronic Hepatitis C: The Public Health Perspective. J Pediatr Gastroenterol Nutr. 2019.
  • Pre-Emptive Transjugular Intrahepatic Portosystemic Shunt for Acute Variceal Bleed: Choose Your Patient Well! Hepatology 2019.
  • Noradrenaline for Hepatorenal Syndrome in Patients with Acute-on Chronic Liver Failure: Hope Remains! Hepatology 2018
  • Satsangi S. Response to terlipressin in hepatorenal syndrome- Predict to prognosticate! Clin Gastroenterol Hepatol. 2018.
  • Satsangi S. Post-Paracentesis Hemoperitoneum - Time to Become More Careful! Liver Int. 2018.
  • Satsangi S. To use entecavir, tenofovir disoproxil fumarate or tenofovir alafenamide. It's all about choosing the right patient! Eur J Gastroenterol Hepatol. 2018.
  • Satsangi S. Immune-tolerant chronic hepatitis B infection- Is the liver really tolerating? J Clin Exp Hepatol. 2018.
  • Satsangi S. Khat consumption induced chronic liver disease: is it all autoimmune?. J Liver Res Disord Ther. 2018;4(2):64.
  • Satsangi S, Mehta M, Duseja A, Taneja S, Dhiman RK, Chawla Y. Dual treatment with sofosbuvir plus ribavirin is as effective as triple therapy with pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patients with chronic hepatitis C. J Gastroenterol Hepatol. 2016.
  • Mehta M, Satsangi S, Duseja A, et al. Can Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease Co-Exist? J Clin Exp Hepatol 2017.
  • Sakpal M, Satsangi S, Mehta M et al. Vitamin D supplementation in patients with Nonalcoholic Fatty Liver Disease - A Randomised Controlled Trial. J Gastroenterol Hepatol Open 2017.
  • Satsangi S, Acharya V, Kini H, Anupama K. An unusual cause of lung mass in a young female. Lung India. 2014;31(2):188-90.
  • Satsangi S, Chawla YK. Viral hepatitis: Indian scenario. Med J Armed Forces India. 2016;72(3):204-10.
  • Dhiman RK, Satsangi S, Grover GS, Puri P. Tackling the burden of hepatitis C in Punjab, India. J Clin Exp Hepatol. 2016 Sep;6(3):224-232.
  • Chronic hepatitis C: Suspect, Detect & Treat. Sandeep Satsangi, Yogesh. K Chawla. (Association of physicians of India 'Medicine update' 2015).
  • Recent advances in the medical management of portal hypertesion. Sandeep Satsangi, Yogesh. K Chawla. (Association of physicians of India 'Medicine update' 2016)
  • How will I manage CHC genotype-1 after the introduction of Direct-Acting Antivirals. Sandeep Satsangi, Yogesh. K Chawla. (Progress in Gastroenterology & Hepatology 2015)
  • Satsangi S, Gupta N. Rheumatologic Manifestations of Viral Hepatitis B and C. Hepatitis. 2015.
  • Satsangi S, Dhiman RK. Combating the wrath of viral hepatitis in India. Indian J Med Res. 2016 Jul; 144(1): 1–5.
  • Treatment of Hepatitis B in the Indian subcontinent. Sandeep Satsangi, Yogesh. K Chawla. Indian College of Physicians Monograph 2017.
  • Acute-on-chronic liver failure - The Newer Paradigm. Sandeep Satsangi, Yogesh. K Chawla. Indian College of Physicians Monograph 2017.
  • NASH: Do we really have an Effective Treatment? Sandeep Satsangi, Ajay Duseja. (Association of physicians of India 'Medicine update' 2017).
  • Dhiman RK, Satsangi S. Autoimmune diseases of the liver. Indian J Med Res. 2017 Jan; 145(1): 151–153.

    Languages Spoken

  • English
  • Hindi
  • Telugu
  • Kannada

    • Overview

  • Dr. Sandeep Satsangi is a top hepatologist and liver transplant doctor in Kanakapura Road, Bangalore, with over 20+ years of experience in treating complex liver diseases. He is currently practising as a Lead Consultant – Hepatology and Transplant Hepatology  at Manipal Hospital, Kanakapura Road. Dr. Sandeep is particularly known for his evidence-based practice and patient-centric care for advanced liver conditions, liver transplantation, and managing multiorgan complications.

  • Dr. Satsangi completed his MBBS from MNR Medical College, Sangareddy, and went on to earn an MD in Internal Medicine from Kasturba Medical College, Mangalore, under Manipal University, which he completed as the university topper. With a particular interest in hepatological disorders, he completed his DM in Hepatology and Liver Transplantation at the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh. With extensive training and residency at his alma mater, Dr. Satsangi gained hands-on experience in managing fatty liver, portal hypertension, acute and chronic liver disease, cirrhosis, viral hepatitis, liver cancer, and acute liver failure.

  • At Manipal Hospital Kanakapura Road, Dr. Sandeep Satsangi plays a pivotal role in the liver transplant programme. He is deeply involved in both pre- and post-transplant patient and donor care, ensuring the smooth surgical and regenerative journey of live donors. A dedicated academic, his research contributions include award-winning papers presented at major international conferences (APASL, AASLD), covering topics such as transplantation outcomes, Hepatitis C management, and ACLF strategies.

  • Dr. Sandeep Satsangi has actively participated in telemedicine initiatives like the ‘ECHO’ programme in Punjab, effectively training community doctors in early liver disease detection and care. He also served as an Assistant Editor for the Journal of Clinical and Experimental Hepatology, underscoring his expertise in scientific review and publication. Known for his compassionate, multilingual ability to converse in English, Hindi, Telugu, Punjabi, and Kannada), Dr. Satsangi seamlessly integrates cutting-edge medical science with personalised care, making him a preferred liver specialist in Kanakapura Road, Bangalore.

    • Field of Expertise

  • Complex Hepatobiliary Conditions.
  • Non-alcoholic fatty liver disease.
  • Alcoholic liver diseases.
  • Cirrhosis of the liver.
  • Acute liver failure.
  • Liver Cancer.
  • Liver Transplantation.
  • Liver Cancer.
  • Liver Transplantation.

    • Awards & Achievements

  • MD: Best outgoing student 2011 batch, scored first rank in the Cardiology-Respiratory Medicine exam, and secured first prize in the M.D intercollegiate quiz competition (2013) held at Cochin, India.
  • DM: Topped the exam held at the distinguished institute of PGI, Chandigarh in 2016.
  • He also received the FIRST prize in the plenary session for the best paper award for an oral presentation on “Monocyte HLA-DR expression, neutrophil oxidative burst capacity and cytokine analysis in patients with decompensated cirrhosis with and without acute-on-chronic liver failure (ACLF)” in Delhi.
  • Served as the Assistant Editor of the prestigious Journal of Clinical and Experimental Hepatology from July 2016 to July 2017, which is an International peer-reviewed journal of Hepatology.
  • Actively assisted Prof. R.K Dhiman and his team in the process of devising the scientific program and abstract evaluation for INASL 2016 & ISHEN 2017.
  • Was actively involved in training the community level physicians in the state of Punjab, India in the field of Hepatology under the guidance of Prof. R.K Dhiman via. the program ‘ECHO’, which involves telemedicine services.

    • Talks & Publications

  • Hepatic Visceral Crisis in Breast Cancer: Targeting an Old Enemy With “Precision” Resulting in Excellent Outcomes. JCEH 2025.
  • Exploring the prevalence, clinical parameters and impact of culture proven ascitic fluid infections in Cirrhosis: A multi-center study. JCEH 2025.
  • The potential liver donor with tuberculosis: A fresh look at international recommendations based on a survey of practice in Indian liver transplant centres. National Med Journal 2022.
  • Fatal Herpes Simplex Hepatitis in a Live Liver Donor. JCEH 2025.
  • Kaur S, Satsangi S et al. Awareness regarding hepatitis B prevention and management of hepatitis B virus positive patients among nurses. J Postgrad Med Edu Res 2023.
  • Satsangi S, Taneja S. Abnormal LFTs in Rheumatic diseases. Rheumatology Clinics 2023.
  • Satsangi S, Taneja S. Anti Tubercular Therapy related hepatitis. Tuberculosis and GIT 2022.
  • Satsangi S et al. Current and new drugs for COVID 19 treatment and its effects on the liver. J Clin Transl Hepatol 2021.
  • Decentralized Care with Generic Direct-Acting Antivirals in the Management of Chronic Hepatitis C in a Public Health Care Setting. J Hepatol. July 2019.
  • Direct-acting antiviral Therapy Is Safe and Effective in Pediatric Chronic Hepatitis C: The Public Health Perspective. J Pediatr Gastroenterol Nutr. 2019.
  • Pre-Emptive Transjugular Intrahepatic Portosystemic Shunt for Acute Variceal Bleed: Choose Your Patient Well! Hepatology 2019.
  • Noradrenaline for Hepatorenal Syndrome in Patients with Acute-on Chronic Liver Failure: Hope Remains! Hepatology 2018
  • Satsangi S. Response to terlipressin in hepatorenal syndrome- Predict to prognosticate! Clin Gastroenterol Hepatol. 2018.
  • Satsangi S. Post-Paracentesis Hemoperitoneum - Time to Become More Careful! Liver Int. 2018.
  • Satsangi S. To use entecavir, tenofovir disoproxil fumarate or tenofovir alafenamide. It's all about choosing the right patient! Eur J Gastroenterol Hepatol. 2018.
  • Satsangi S. Immune-tolerant chronic hepatitis B infection- Is the liver really tolerating? J Clin Exp Hepatol. 2018.
  • Satsangi S. Khat consumption induced chronic liver disease: is it all autoimmune?. J Liver Res Disord Ther. 2018;4(2):64.
  • Satsangi S, Mehta M, Duseja A, Taneja S, Dhiman RK, Chawla Y. Dual treatment with sofosbuvir plus ribavirin is as effective as triple therapy with pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patients with chronic hepatitis C. J Gastroenterol Hepatol. 2016.
  • Mehta M, Satsangi S, Duseja A, et al. Can Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease Co-Exist? J Clin Exp Hepatol 2017.
  • Sakpal M, Satsangi S, Mehta M et al. Vitamin D supplementation in patients with Nonalcoholic Fatty Liver Disease - A Randomised Controlled Trial. J Gastroenterol Hepatol Open 2017.
  • Satsangi S, Acharya V, Kini H, Anupama K. An unusual cause of lung mass in a young female. Lung India. 2014;31(2):188-90.
  • Satsangi S, Chawla YK. Viral hepatitis: Indian scenario. Med J Armed Forces India. 2016;72(3):204-10.
  • Dhiman RK, Satsangi S, Grover GS, Puri P. Tackling the burden of hepatitis C in Punjab, India. J Clin Exp Hepatol. 2016 Sep;6(3):224-232.
  • Chronic hepatitis C: Suspect, Detect & Treat. Sandeep Satsangi, Yogesh. K Chawla. (Association of physicians of India 'Medicine update' 2015).
  • Recent advances in the medical management of portal hypertesion. Sandeep Satsangi, Yogesh. K Chawla. (Association of physicians of India 'Medicine update' 2016)
  • How will I manage CHC genotype-1 after the introduction of Direct-Acting Antivirals. Sandeep Satsangi, Yogesh. K Chawla. (Progress in Gastroenterology & Hepatology 2015)
  • Satsangi S, Gupta N. Rheumatologic Manifestations of Viral Hepatitis B and C. Hepatitis. 2015.
  • Satsangi S, Dhiman RK. Combating the wrath of viral hepatitis in India. Indian J Med Res. 2016 Jul; 144(1): 1–5.
  • Treatment of Hepatitis B in the Indian subcontinent. Sandeep Satsangi, Yogesh. K Chawla. Indian College of Physicians Monograph 2017.
  • Acute-on-chronic liver failure - The Newer Paradigm. Sandeep Satsangi, Yogesh. K Chawla. Indian College of Physicians Monograph 2017.
  • NASH: Do we really have an Effective Treatment? Sandeep Satsangi, Ajay Duseja. (Association of physicians of India 'Medicine update' 2017).
  • Dhiman RK, Satsangi S. Autoimmune diseases of the liver. Indian J Med Res. 2017 Jan; 145(1): 151–153.

    Field of Expertise

  • Complex Hepatobiliary Conditions.
  • Non-alcoholic fatty liver disease.
  • Alcoholic liver diseases.
  • Cirrhosis of the liver.
  • Acute liver failure.
  • Liver Cancer.
  • Liver Transplantation.
  • Liver Cancer.
  • Liver Transplantation.

    • Languages Spoken

  • English
  • Hindi
  • Telugu
  • Kannada

    • Awards & Achievements

  • MD: Best outgoing student 2011 batch, scored first rank in the Cardiology-Respiratory Medicine exam, and secured first prize in the M.D intercollegiate quiz competition (2013) held at Cochin, India.
  • DM: Topped the exam held at the distinguished institute of PGI, Chandigarh in 2016.
  • He also received the FIRST prize in the plenary session for the best paper award for an oral presentation on “Monocyte HLA-DR expression, neutrophil oxidative burst capacity and cytokine analysis in patients with decompensated cirrhosis with and without acute-on-chronic liver failure (ACLF)” in Delhi.
  • Served as the Assistant Editor of the prestigious Journal of Clinical and Experimental Hepatology from July 2016 to July 2017, which is an International peer-reviewed journal of Hepatology.
  • Actively assisted Prof. R.K Dhiman and his team in the process of devising the scientific program and abstract evaluation for INASL 2016 & ISHEN 2017.
  • Was actively involved in training the community level physicians in the state of Punjab, India in the field of Hepatology under the guidance of Prof. R.K Dhiman via. the program ‘ECHO’, which involves telemedicine services.

    • Talks & Publications

  • Hepatic Visceral Crisis in Breast Cancer: Targeting an Old Enemy With “Precision” Resulting in Excellent Outcomes. JCEH 2025.
  • Exploring the prevalence, clinical parameters and impact of culture proven ascitic fluid infections in Cirrhosis: A multi-center study. JCEH 2025.
  • The potential liver donor with tuberculosis: A fresh look at international recommendations based on a survey of practice in Indian liver transplant centres. National Med Journal 2022.
  • Fatal Herpes Simplex Hepatitis in a Live Liver Donor. JCEH 2025.
  • Kaur S, Satsangi S et al. Awareness regarding hepatitis B prevention and management of hepatitis B virus positive patients among nurses. J Postgrad Med Edu Res 2023.
  • Satsangi S, Taneja S. Abnormal LFTs in Rheumatic diseases. Rheumatology Clinics 2023.
  • Satsangi S, Taneja S. Anti Tubercular Therapy related hepatitis. Tuberculosis and GIT 2022.
  • Satsangi S et al. Current and new drugs for COVID 19 treatment and its effects on the liver. J Clin Transl Hepatol 2021.
  • Decentralized Care with Generic Direct-Acting Antivirals in the Management of Chronic Hepatitis C in a Public Health Care Setting. J Hepatol. July 2019.
  • Direct-acting antiviral Therapy Is Safe and Effective in Pediatric Chronic Hepatitis C: The Public Health Perspective. J Pediatr Gastroenterol Nutr. 2019.
  • Pre-Emptive Transjugular Intrahepatic Portosystemic Shunt for Acute Variceal Bleed: Choose Your Patient Well! Hepatology 2019.
  • Noradrenaline for Hepatorenal Syndrome in Patients with Acute-on Chronic Liver Failure: Hope Remains! Hepatology 2018
  • Satsangi S. Response to terlipressin in hepatorenal syndrome- Predict to prognosticate! Clin Gastroenterol Hepatol. 2018.
  • Satsangi S. Post-Paracentesis Hemoperitoneum - Time to Become More Careful! Liver Int. 2018.
  • Satsangi S. To use entecavir, tenofovir disoproxil fumarate or tenofovir alafenamide. It's all about choosing the right patient! Eur J Gastroenterol Hepatol. 2018.
  • Satsangi S. Immune-tolerant chronic hepatitis B infection- Is the liver really tolerating? J Clin Exp Hepatol. 2018.
  • Satsangi S. Khat consumption induced chronic liver disease: is it all autoimmune?. J Liver Res Disord Ther. 2018;4(2):64.
  • Satsangi S, Mehta M, Duseja A, Taneja S, Dhiman RK, Chawla Y. Dual treatment with sofosbuvir plus ribavirin is as effective as triple therapy with pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patients with chronic hepatitis C. J Gastroenterol Hepatol. 2016.
  • Mehta M, Satsangi S, Duseja A, et al. Can Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease Co-Exist? J Clin Exp Hepatol 2017.
  • Sakpal M, Satsangi S, Mehta M et al. Vitamin D supplementation in patients with Nonalcoholic Fatty Liver Disease - A Randomised Controlled Trial. J Gastroenterol Hepatol Open 2017.
  • Satsangi S, Acharya V, Kini H, Anupama K. An unusual cause of lung mass in a young female. Lung India. 2014;31(2):188-90.
  • Satsangi S, Chawla YK. Viral hepatitis: Indian scenario. Med J Armed Forces India. 2016;72(3):204-10.
  • Dhiman RK, Satsangi S, Grover GS, Puri P. Tackling the burden of hepatitis C in Punjab, India. J Clin Exp Hepatol. 2016 Sep;6(3):224-232.
  • Chronic hepatitis C: Suspect, Detect & Treat. Sandeep Satsangi, Yogesh. K Chawla. (Association of physicians of India 'Medicine update' 2015).
  • Recent advances in the medical management of portal hypertesion. Sandeep Satsangi, Yogesh. K Chawla. (Association of physicians of India 'Medicine update' 2016)
  • How will I manage CHC genotype-1 after the introduction of Direct-Acting Antivirals. Sandeep Satsangi, Yogesh. K Chawla. (Progress in Gastroenterology & Hepatology 2015)
  • Satsangi S, Gupta N. Rheumatologic Manifestations of Viral Hepatitis B and C. Hepatitis. 2015.
  • Satsangi S, Dhiman RK. Combating the wrath of viral hepatitis in India. Indian J Med Res. 2016 Jul; 144(1): 1–5.
  • Treatment of Hepatitis B in the Indian subcontinent. Sandeep Satsangi, Yogesh. K Chawla. Indian College of Physicians Monograph 2017.
  • Acute-on-chronic liver failure - The Newer Paradigm. Sandeep Satsangi, Yogesh. K Chawla. Indian College of Physicians Monograph 2017.
  • NASH: Do we really have an Effective Treatment? Sandeep Satsangi, Ajay Duseja. (Association of physicians of India 'Medicine update' 2017).
  • Dhiman RK, Satsangi S. Autoimmune diseases of the liver. Indian J Med Res. 2017 Jan; 145(1): 151–153.

    • Overview

  • Dr. Sandeep Satsangi is a top hepatologist and liver transplant doctor in Kanakapura Road, Bangalore, with over 20+ years of experience in treating complex liver diseases. He is currently practising as a Lead Consultant – Hepatology and Transplant Hepatology  at Manipal Hospital, Kanakapura Road. Dr. Sandeep is particularly known for his evidence-based practice and patient-centric care for advanced liver conditions, liver transplantation, and managing multiorgan complications.

  • Dr. Satsangi completed his MBBS from MNR Medical College, Sangareddy, and went on to earn an MD in Internal Medicine from Kasturba Medical College, Mangalore, under Manipal University, which he completed as the university topper. With a particular interest in hepatological disorders, he completed his DM in Hepatology and Liver Transplantation at the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh. With extensive training and residency at his alma mater, Dr. Satsangi gained hands-on experience in managing fatty liver, portal hypertension, acute and chronic liver disease, cirrhosis, viral hepatitis, liver cancer, and acute liver failure.

  • At Manipal Hospital Kanakapura Road, Dr. Sandeep Satsangi plays a pivotal role in the liver transplant programme. He is deeply involved in both pre- and post-transplant patient and donor care, ensuring the smooth surgical and regenerative journey of live donors. A dedicated academic, his research contributions include award-winning papers presented at major international conferences (APASL, AASLD), covering topics such as transplantation outcomes, Hepatitis C management, and ACLF strategies.

  • Dr. Sandeep Satsangi has actively participated in telemedicine initiatives like the ‘ECHO’ programme in Punjab, effectively training community doctors in early liver disease detection and care. He also served as an Assistant Editor for the Journal of Clinical and Experimental Hepatology, underscoring his expertise in scientific review and publication. Known for his compassionate, multilingual ability to converse in English, Hindi, Telugu, Punjabi, and Kannada), Dr. Satsangi seamlessly integrates cutting-edge medical science with personalised care, making him a preferred liver specialist in Kanakapura Road, Bangalore.

    Awards & Achievements

  • MD: Best outgoing student 2011 batch, scored first rank in the Cardiology-Respiratory Medicine exam, and secured first prize in the M.D intercollegiate quiz competition (2013) held at Cochin, India.
  • DM: Topped the exam held at the distinguished institute of PGI, Chandigarh in 2016.
  • He also received the FIRST prize in the plenary session for the best paper award for an oral presentation on “Monocyte HLA-DR expression, neutrophil oxidative burst capacity and cytokine analysis in patients with decompensated cirrhosis with and without acute-on-chronic liver failure (ACLF)” in Delhi.
  • Served as the Assistant Editor of the prestigious Journal of Clinical and Experimental Hepatology from July 2016 to July 2017, which is an International peer-reviewed journal of Hepatology.
  • Actively assisted Prof. R.K Dhiman and his team in the process of devising the scientific program and abstract evaluation for INASL 2016 & ISHEN 2017.
  • Was actively involved in training the community level physicians in the state of Punjab, India in the field of Hepatology under the guidance of Prof. R.K Dhiman via. the program ‘ECHO’, which involves telemedicine services.

    • Field of Expertise

  • Complex Hepatobiliary Conditions.
  • Non-alcoholic fatty liver disease.
  • Alcoholic liver diseases.
  • Cirrhosis of the liver.
  • Acute liver failure.
  • Liver Cancer.
  • Liver Transplantation.
  • Liver Cancer.
  • Liver Transplantation.

    • Languages Spoken

  • English
  • Hindi
  • Telugu
  • Kannada

    • Talks & Publications

  • Hepatic Visceral Crisis in Breast Cancer: Targeting an Old Enemy With “Precision” Resulting in Excellent Outcomes. JCEH 2025.
  • Exploring the prevalence, clinical parameters and impact of culture proven ascitic fluid infections in Cirrhosis: A multi-center study. JCEH 2025.
  • The potential liver donor with tuberculosis: A fresh look at international recommendations based on a survey of practice in Indian liver transplant centres. National Med Journal 2022.
  • Fatal Herpes Simplex Hepatitis in a Live Liver Donor. JCEH 2025.
  • Kaur S, Satsangi S et al. Awareness regarding hepatitis B prevention and management of hepatitis B virus positive patients among nurses. J Postgrad Med Edu Res 2023.
  • Satsangi S, Taneja S. Abnormal LFTs in Rheumatic diseases. Rheumatology Clinics 2023.
  • Satsangi S, Taneja S. Anti Tubercular Therapy related hepatitis. Tuberculosis and GIT 2022.
  • Satsangi S et al. Current and new drugs for COVID 19 treatment and its effects on the liver. J Clin Transl Hepatol 2021.
  • Decentralized Care with Generic Direct-Acting Antivirals in the Management of Chronic Hepatitis C in a Public Health Care Setting. J Hepatol. July 2019.
  • Direct-acting antiviral Therapy Is Safe and Effective in Pediatric Chronic Hepatitis C: The Public Health Perspective. J Pediatr Gastroenterol Nutr. 2019.
  • Pre-Emptive Transjugular Intrahepatic Portosystemic Shunt for Acute Variceal Bleed: Choose Your Patient Well! Hepatology 2019.
  • Noradrenaline for Hepatorenal Syndrome in Patients with Acute-on Chronic Liver Failure: Hope Remains! Hepatology 2018
  • Satsangi S. Response to terlipressin in hepatorenal syndrome- Predict to prognosticate! Clin Gastroenterol Hepatol. 2018.
  • Satsangi S. Post-Paracentesis Hemoperitoneum - Time to Become More Careful! Liver Int. 2018.
  • Satsangi S. To use entecavir, tenofovir disoproxil fumarate or tenofovir alafenamide. It's all about choosing the right patient! Eur J Gastroenterol Hepatol. 2018.
  • Satsangi S. Immune-tolerant chronic hepatitis B infection- Is the liver really tolerating? J Clin Exp Hepatol. 2018.
  • Satsangi S. Khat consumption induced chronic liver disease: is it all autoimmune?. J Liver Res Disord Ther. 2018;4(2):64.
  • Satsangi S, Mehta M, Duseja A, Taneja S, Dhiman RK, Chawla Y. Dual treatment with sofosbuvir plus ribavirin is as effective as triple therapy with pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patients with chronic hepatitis C. J Gastroenterol Hepatol. 2016.
  • Mehta M, Satsangi S, Duseja A, et al. Can Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease Co-Exist? J Clin Exp Hepatol 2017.
  • Sakpal M, Satsangi S, Mehta M et al. Vitamin D supplementation in patients with Nonalcoholic Fatty Liver Disease - A Randomised Controlled Trial. J Gastroenterol Hepatol Open 2017.
  • Satsangi S, Acharya V, Kini H, Anupama K. An unusual cause of lung mass in a young female. Lung India. 2014;31(2):188-90.
  • Satsangi S, Chawla YK. Viral hepatitis: Indian scenario. Med J Armed Forces India. 2016;72(3):204-10.
  • Dhiman RK, Satsangi S, Grover GS, Puri P. Tackling the burden of hepatitis C in Punjab, India. J Clin Exp Hepatol. 2016 Sep;6(3):224-232.
  • Chronic hepatitis C: Suspect, Detect & Treat. Sandeep Satsangi, Yogesh. K Chawla. (Association of physicians of India 'Medicine update' 2015).
  • Recent advances in the medical management of portal hypertesion. Sandeep Satsangi, Yogesh. K Chawla. (Association of physicians of India 'Medicine update' 2016)
  • How will I manage CHC genotype-1 after the introduction of Direct-Acting Antivirals. Sandeep Satsangi, Yogesh. K Chawla. (Progress in Gastroenterology & Hepatology 2015)
  • Satsangi S, Gupta N. Rheumatologic Manifestations of Viral Hepatitis B and C. Hepatitis. 2015.
  • Satsangi S, Dhiman RK. Combating the wrath of viral hepatitis in India. Indian J Med Res. 2016 Jul; 144(1): 1–5.
  • Treatment of Hepatitis B in the Indian subcontinent. Sandeep Satsangi, Yogesh. K Chawla. Indian College of Physicians Monograph 2017.
  • Acute-on-chronic liver failure - The Newer Paradigm. Sandeep Satsangi, Yogesh. K Chawla. Indian College of Physicians Monograph 2017.
  • NASH: Do we really have an Effective Treatment? Sandeep Satsangi, Ajay Duseja. (Association of physicians of India 'Medicine update' 2017).
  • Dhiman RK, Satsangi S. Autoimmune diseases of the liver. Indian J Med Res. 2017 Jan; 145(1): 151–153.

    • Overview

  • Dr. Sandeep Satsangi is a top hepatologist and liver transplant doctor in Kanakapura Road, Bangalore, with over 20+ years of experience in treating complex liver diseases. He is currently practising as a Lead Consultant – Hepatology and Transplant Hepatology  at Manipal Hospital, Kanakapura Road. Dr. Sandeep is particularly known for his evidence-based practice and patient-centric care for advanced liver conditions, liver transplantation, and managing multiorgan complications.

  • Dr. Satsangi completed his MBBS from MNR Medical College, Sangareddy, and went on to earn an MD in Internal Medicine from Kasturba Medical College, Mangalore, under Manipal University, which he completed as the university topper. With a particular interest in hepatological disorders, he completed his DM in Hepatology and Liver Transplantation at the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh. With extensive training and residency at his alma mater, Dr. Satsangi gained hands-on experience in managing fatty liver, portal hypertension, acute and chronic liver disease, cirrhosis, viral hepatitis, liver cancer, and acute liver failure.

  • At Manipal Hospital Kanakapura Road, Dr. Sandeep Satsangi plays a pivotal role in the liver transplant programme. He is deeply involved in both pre- and post-transplant patient and donor care, ensuring the smooth surgical and regenerative journey of live donors. A dedicated academic, his research contributions include award-winning papers presented at major international conferences (APASL, AASLD), covering topics such as transplantation outcomes, Hepatitis C management, and ACLF strategies.

  • Dr. Sandeep Satsangi has actively participated in telemedicine initiatives like the ‘ECHO’ programme in Punjab, effectively training community doctors in early liver disease detection and care. He also served as an Assistant Editor for the Journal of Clinical and Experimental Hepatology, underscoring his expertise in scientific review and publication. Known for his compassionate, multilingual ability to converse in English, Hindi, Telugu, Punjabi, and Kannada), Dr. Satsangi seamlessly integrates cutting-edge medical science with personalised care, making him a preferred liver specialist in Kanakapura Road, Bangalore.

    Talks & Publications

  • Hepatic Visceral Crisis in Breast Cancer: Targeting an Old Enemy With “Precision” Resulting in Excellent Outcomes. JCEH 2025.
  • Exploring the prevalence, clinical parameters and impact of culture proven ascitic fluid infections in Cirrhosis: A multi-center study. JCEH 2025.
  • The potential liver donor with tuberculosis: A fresh look at international recommendations based on a survey of practice in Indian liver transplant centres. National Med Journal 2022.
  • Fatal Herpes Simplex Hepatitis in a Live Liver Donor. JCEH 2025.
  • Kaur S, Satsangi S et al. Awareness regarding hepatitis B prevention and management of hepatitis B virus positive patients among nurses. J Postgrad Med Edu Res 2023.
  • Satsangi S, Taneja S. Abnormal LFTs in Rheumatic diseases. Rheumatology Clinics 2023.
  • Satsangi S, Taneja S. Anti Tubercular Therapy related hepatitis. Tuberculosis and GIT 2022.
  • Satsangi S et al. Current and new drugs for COVID 19 treatment and its effects on the liver. J Clin Transl Hepatol 2021.
  • Decentralized Care with Generic Direct-Acting Antivirals in the Management of Chronic Hepatitis C in a Public Health Care Setting. J Hepatol. July 2019.
  • Direct-acting antiviral Therapy Is Safe and Effective in Pediatric Chronic Hepatitis C: The Public Health Perspective. J Pediatr Gastroenterol Nutr. 2019.
  • Pre-Emptive Transjugular Intrahepatic Portosystemic Shunt for Acute Variceal Bleed: Choose Your Patient Well! Hepatology 2019.
  • Noradrenaline for Hepatorenal Syndrome in Patients with Acute-on Chronic Liver Failure: Hope Remains! Hepatology 2018
  • Satsangi S. Response to terlipressin in hepatorenal syndrome- Predict to prognosticate! Clin Gastroenterol Hepatol. 2018.
  • Satsangi S. Post-Paracentesis Hemoperitoneum - Time to Become More Careful! Liver Int. 2018.
  • Satsangi S. To use entecavir, tenofovir disoproxil fumarate or tenofovir alafenamide. It's all about choosing the right patient! Eur J Gastroenterol Hepatol. 2018.
  • Satsangi S. Immune-tolerant chronic hepatitis B infection- Is the liver really tolerating? J Clin Exp Hepatol. 2018.
  • Satsangi S. Khat consumption induced chronic liver disease: is it all autoimmune?. J Liver Res Disord Ther. 2018;4(2):64.
  • Satsangi S, Mehta M, Duseja A, Taneja S, Dhiman RK, Chawla Y. Dual treatment with sofosbuvir plus ribavirin is as effective as triple therapy with pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patients with chronic hepatitis C. J Gastroenterol Hepatol. 2016.
  • Mehta M, Satsangi S, Duseja A, et al. Can Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease Co-Exist? J Clin Exp Hepatol 2017.
  • Sakpal M, Satsangi S, Mehta M et al. Vitamin D supplementation in patients with Nonalcoholic Fatty Liver Disease - A Randomised Controlled Trial. J Gastroenterol Hepatol Open 2017.
  • Satsangi S, Acharya V, Kini H, Anupama K. An unusual cause of lung mass in a young female. Lung India. 2014;31(2):188-90.
  • Satsangi S, Chawla YK. Viral hepatitis: Indian scenario. Med J Armed Forces India. 2016;72(3):204-10.
  • Dhiman RK, Satsangi S, Grover GS, Puri P. Tackling the burden of hepatitis C in Punjab, India. J Clin Exp Hepatol. 2016 Sep;6(3):224-232.
  • Chronic hepatitis C: Suspect, Detect & Treat. Sandeep Satsangi, Yogesh. K Chawla. (Association of physicians of India 'Medicine update' 2015).
  • Recent advances in the medical management of portal hypertesion. Sandeep Satsangi, Yogesh. K Chawla. (Association of physicians of India 'Medicine update' 2016)
  • How will I manage CHC genotype-1 after the introduction of Direct-Acting Antivirals. Sandeep Satsangi, Yogesh. K Chawla. (Progress in Gastroenterology & Hepatology 2015)
  • Satsangi S, Gupta N. Rheumatologic Manifestations of Viral Hepatitis B and C. Hepatitis. 2015.
  • Satsangi S, Dhiman RK. Combating the wrath of viral hepatitis in India. Indian J Med Res. 2016 Jul; 144(1): 1–5.
  • Treatment of Hepatitis B in the Indian subcontinent. Sandeep Satsangi, Yogesh. K Chawla. Indian College of Physicians Monograph 2017.
  • Acute-on-chronic liver failure - The Newer Paradigm. Sandeep Satsangi, Yogesh. K Chawla. Indian College of Physicians Monograph 2017.
  • NASH: Do we really have an Effective Treatment? Sandeep Satsangi, Ajay Duseja. (Association of physicians of India 'Medicine update' 2017).
  • Dhiman RK, Satsangi S. Autoimmune diseases of the liver. Indian J Med Res. 2017 Jan; 145(1): 151–153.

    • Overview

  • Dr. Sandeep Satsangi is a top hepatologist and liver transplant doctor in Kanakapura Road, Bangalore, with over 20+ years of experience in treating complex liver diseases. He is currently practising as a Lead Consultant – Hepatology and Transplant Hepatology  at Manipal Hospital, Kanakapura Road. Dr. Sandeep is particularly known for his evidence-based practice and patient-centric care for advanced liver conditions, liver transplantation, and managing multiorgan complications.

  • Dr. Satsangi completed his MBBS from MNR Medical College, Sangareddy, and went on to earn an MD in Internal Medicine from Kasturba Medical College, Mangalore, under Manipal University, which he completed as the university topper. With a particular interest in hepatological disorders, he completed his DM in Hepatology and Liver Transplantation at the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh. With extensive training and residency at his alma mater, Dr. Satsangi gained hands-on experience in managing fatty liver, portal hypertension, acute and chronic liver disease, cirrhosis, viral hepatitis, liver cancer, and acute liver failure.

  • At Manipal Hospital Kanakapura Road, Dr. Sandeep Satsangi plays a pivotal role in the liver transplant programme. He is deeply involved in both pre- and post-transplant patient and donor care, ensuring the smooth surgical and regenerative journey of live donors. A dedicated academic, his research contributions include award-winning papers presented at major international conferences (APASL, AASLD), covering topics such as transplantation outcomes, Hepatitis C management, and ACLF strategies.

  • Dr. Sandeep Satsangi has actively participated in telemedicine initiatives like the ‘ECHO’ programme in Punjab, effectively training community doctors in early liver disease detection and care. He also served as an Assistant Editor for the Journal of Clinical and Experimental Hepatology, underscoring his expertise in scientific review and publication. Known for his compassionate, multilingual ability to converse in English, Hindi, Telugu, Punjabi, and Kannada), Dr. Satsangi seamlessly integrates cutting-edge medical science with personalised care, making him a preferred liver specialist in Kanakapura Road, Bangalore.

    • Field of Expertise

  • Complex Hepatobiliary Conditions.
  • Non-alcoholic fatty liver disease.
  • Alcoholic liver diseases.
  • Cirrhosis of the liver.
  • Acute liver failure.
  • Liver Cancer.
  • Liver Transplantation.
  • Liver Cancer.
  • Liver Transplantation.

    • Languages Spoken

  • English
  • Hindi
  • Telugu
  • Kannada

    • Awards & Achievements

  • MD: Best outgoing student 2011 batch, scored first rank in the Cardiology-Respiratory Medicine exam, and secured first prize in the M.D intercollegiate quiz competition (2013) held at Cochin, India.
  • DM: Topped the exam held at the distinguished institute of PGI, Chandigarh in 2016.
  • He also received the FIRST prize in the plenary session for the best paper award for an oral presentation on “Monocyte HLA-DR expression, neutrophil oxidative burst capacity and cytokine analysis in patients with decompensated cirrhosis with and without acute-on-chronic liver failure (ACLF)” in Delhi.
  • Served as the Assistant Editor of the prestigious Journal of Clinical and Experimental Hepatology from July 2016 to July 2017, which is an International peer-reviewed journal of Hepatology.
  • Actively assisted Prof. R.K Dhiman and his team in the process of devising the scientific program and abstract evaluation for INASL 2016 & ISHEN 2017.
  • Was actively involved in training the community level physicians in the state of Punjab, India in the field of Hepatology under the guidance of Prof. R.K Dhiman via. the program ‘ECHO’, which involves telemedicine services.

Blogs

FAQ's

Patients visit Dr. Sandeep Satsangi, a leading Lead Consultant - Hepatology and Transplant Hepatology at Manipal Hospitals Kanakapura Road - Bengaluru, for expert care and advanced treatments. Known for accurate diagnoses and patient centric care, Dr. Sandeep Satsangi is a trusted choice for exceptional medical support.

Home Kanakapuraroad Doctors Dr-sandeep-satsangi-hepatologist-and-liver-transplant-specialist

You’re on Our Indian Website

Visit the Global site for International patient services

Appointment
Health Check
Home Care
Contact Us
review icon
Review Us
Call Us